Evidence map›Paper›PMID 41961378›Full record

ArticleEnvironmental geochemistry and health2026

Lung cancer risk in relation to indicative radon atlas metrics in Northern Ireland: a population-based case-control study using secondary data.

Claire M Delargy, Helen G Coleman, Quentin G Crowley, Damien Bennett, Javier Elio, Deirdre Fitzpatrick, Helen Mitchell, Sara M Wallace, Rawan A N Alhattab, Angela Scott and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Environmental geochemistry and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Claire M DelargyCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Helen G ColemanCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Quentin G CrowleyGeology, School of Natural Sciences, Trinity College Dublin, Dublin, Republic of Ireland.
Damien BennettCentre for Public Health, Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, Northern Ireland.
Javier ElioWestern Norway University of Applied Sciences, Bergen, Norway.
Deirdre FitzpatrickCentre for Public Health, Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, Northern Ireland.
Helen MitchellCentre for Public Health, Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, Northern Ireland.
Sara M WallaceCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Rawan A N AlhattabCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Angela ScottCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Bernadette McGuinnessCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Ruth F HunterCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Gareth J McKayCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland.
Daniel R S MiddletonCentre for Public Health, Institute of Clinical Sciences B, Queen's University Belfast, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland. d.middleton@qub.ac.uk.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Radon is an established lung carcinogen, but more research is needed to inform whether area-based measures of radon exposure reflect underlying cancer risk. This study, the first of its kind in the UK, aimed to investigate the association between a nationwide indicative radon atlas and lung cancer risk in Northern Ireland, a region in which lung cancer screening programmes are under design. A population-based case-control study was conducted. Primary lung cancer cases (n = 1,687) from the Northern Ireland Cancer Registry diagnosed in 2006 and 2014 were compared with 8,094 non-lung cancer controls from a large cohort. Radon exposure data were extracted from the Indicative Atlas of Radon, which categorises 1 km

Indexed as

Air Pollutants, RadioactiveEnvironmental ExposureLung NeoplasmsRadonAgedCase-Control StudiesFemaleHumansMaleMiddle AgedNorthern IrelandOdds RatioRisk FactorsAir Pollutants, RadioactiveRadonCase–controlLung cancerMappingRadon

Identifiers

PMID41961378
PMCPMC13068683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.